13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-006465-16-DE (EUCTR) | 03/05/2007 | Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MS | Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MS | Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;Term: Relapsing-remitting multiple sclerosis MedDRA version: 9.1;Classification code 10063400;Term: Secondary progressive multiple sclerosis | Trade Name: Genotropin Product Name: Genotropin INN or Proposed INN: human recombinant growth hormone | University of Leipzig | NULL | Not Recruiting | Female: yes Male: yes | Phase 2 | Germany |